Apple Watch: Upgrading or Downgrading? Insights from a Top Analyst
Apple Watch enthusiasts are buzzing as the new Apple Watch Series 10 makes its debut. However, key details emerged from top analyst Mark Gurman that suggest this upgrade could be more of a dilemma than an enhancement. During the recent Glowtime event, a notable absence of Blood Oxygen monitoring in the new model raised eyebrows, primarily due to ongoing patent conflicts with Masimo.
For users of the Apple Watch Series 6 or newer, this might signal a decision point—whether to upgrade or stick with their current model. Upgraders might find that the technological advancements do not outweigh this particular omission, as the Blood Oxygen monitoring feature is a critical health tool for many.
Why Apple Watch Series 10 Might Be a Downgrade
The technological landscape is shifting, and the expectations for smartwatch capabilities continue to rise. The decision to refrain from including Blood Oxygen monitoring could cause significant implications regarding health monitoring.
Analyzing the Analyst's Points
- Ongoing patent dispute with Masimo compromises feature set.
- Potential deterrence for existing users considering an upgrade.
- Market implications for future Apple Watch iterations.
Final Thoughts on Upgrading
For potential upgraders, it is essential to weigh the absence of this critical feature against the new functionalities offered by Series 10. As smartwatches continue to evolve, understanding these limitations will guide informed decisions.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.